Antisecretory and antiinflammatory properties of bismuth subsalicylate

Reviews of Infectious Diseases

Volumn 12, Issue , 1990, Pages S16-S20

  Ericsson, Charles D ^a,b   Tannenbaum, Carl ^a,b   Charles, Terry T ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BISMUTH SALICYLATE; ENTEROTOXIN; INDOMETACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; DOSE RESPONSE; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; INFLAMMATION; INOCULATION; INTESTINE; LIGATION; NONHUMAN; PRIORITY JOURNAL; SECRETION; VIBRIO CHOLERAE;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BISMUTH; DOSE-RESPONSE RELATIONSHIP, DRUG; JEJUNUM; MALE; ORGANOMETALLIC COMPOUNDS; RABBITS; RATS; SALICYLATES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SWINE;

EID: 0025056958     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.Supplement_1.S16     Document Type: Article

References (14)

1. DuPont H.L., Sullivan P., Pickering L.K., Haynes G., Ackerman P.B. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenteritis 1977;73:715–8
2. DuPont H.L., Sullivan P., Evans D.G., Vollet J.J. III, Ericsson C.D., Ackerman P.B., Tjoa W.S. Prevention of travelers’ diarrhea (emporiatric enteritis): prophylactic administration of subsalicylate bismuth. JAMA 1980;243:237–41
3. DuPont H.L., Ericsson C.D., Johnson P.C., Bitsura J.A.M., DuPont M.W., de la Cabada F.J. Preventing travelers’ diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347–50
4. Steffen R., DuPont H.L., Heusser R., Helminger A., Witassek F., Schar M. Prevention of travelers’ diarrhea by the tablet form of bismuth subsalicylate. Antimicrob Agents Chemother 1986;29:625–7
5. Steinhoff M.C., Douglas R.G. Jr, Greenberg H.B., Callahan D.R. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 1980;78:1495–9
6. Gryboski J.D., Hillemeier A.C., Grill B., Kocoshis S. Bismuth subsalicylate in the treatment of chronic diarrhea of childhood. Am J Gastroenterol 1985;80:871–6
7. Graham D.Y., Ester M.K., Gentry L.O. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli- induced diarrhea in volunteers. Gastroenterology 1983; 85:1017–22
8. Ericsson C.D., Evans D.G., DuPont H.L., Evans D.J., Pickering L.K. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis 1977;136:693–6
9. Gyles C.L., Zigler M. The effect of adsorbent and antiinflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli. Canadian Journal of Comparative Medicine 1978;42:260–8
10. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J., Klepper M.S. Enteropooling assay: a test for diarrhea produced by prostaglandins. Prostaglandins 1976;11:809–28
11. Robert A., Nezamis J.E., Lancaster C. Cholera toxin requires gut handling to be enteropooling. Gastroenterology 1983; 84:1287
12. Robert A., Lancaster C., Nezamis J.E. Permissive effect of prostaglandins on enteropooling caused by cholera toxin. Gastroenterology 1983;84:1286
13. DuPont H.L. Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell Clin Pharm 1987;21:687–93
14. Burke V., Gracy M., Suharyono S. Reduction by aspirin of intestinal fluid loss in acute childhood gastroenteritis. Lancet 1980;1:1329–30